{
      "Rank": 419,
      "Acronym": [
            "ACT-AKI"
      ],
      "AgreementOtherDetails": [],
      "AgreementPISponsorEmployee": [],
      "AgreementRestrictionType": [],
      "AgreementRestrictiveAgreement": [],
      "ArmGroupDescription": [
            "Treatment with AC607",
            "Treatment with Placebo"
      ],
      "ArmGroupInterventionName": [
            "Biological: AC607",
            "Biological: Vehicle Only"
      ],
      "ArmGroupLabel": [
            "AC607",
            "Placebo"
      ],
      "ArmGroupType": [
            "Active Comparator",
            "Placebo Comparator"
      ],
      "AvailIPDComment": [],
      "AvailIPDId": [],
      "AvailIPDType": [],
      "AvailIPDURL": [],
      "BaselineCategoryTitle": [],
      "BaselineClassDenomCountGroupId": [],
      "NCTId": [
            "NCT01602328"
      ],
      "BaselineClassDenomCountValue": [],
      "BaselineClassDenomUnits": [],
      "BaselineClassTitle": [],
      "BaselineDenomCountGroupId": [],
      "BaselineDenomCountValue": [],
      "BaselineDenomUnits": [],
      "BaselineGroupDescription": [],
      "BaselineGroupId": [],
      "BaselineGroupTitle": [],
      "BaselineMeasureCalculatePct": [],
      "BaselineMeasureDenomCountGroupId": [],
      "BaselineMeasureDenomCountValue": [],
      "BaselineMeasureDenomUnits": [],
      "BaselineMeasureDenomUnitsSelected": [],
      "BaselineMeasureDescription": [],
      "BaselineMeasureDispersionType": [],
      "BaselineMeasureParamType": [],
      "BaselineMeasurePopulationDescription": [],
      "BaselineMeasureTitle": [],
      "BaselineMeasureUnitOfMeasure": [],
      "BaselineMeasurementComment": [],
      "BaselineMeasurementGroupId": [],
      "BaselineMeasurementLowerLimit": [],
      "BaselineMeasurementSpread": [],
      "BaselineMeasurementUpperLimit": [],
      "BaselineMeasurementValue": [],
      "BaselinePopulationDescription": [],
      "BaselineTypeUnitsAnalyzed": [],
      "BioSpecDescription": [],
      "BioSpecRetention": [],
      "BriefSummary": [
            "Subjects entering the study will have undergone cardiac surgery. Those who experience kidney injury within 48 hours of their surgery will be enrolled into the study. Once enrolled, subjects will receive a single administration of AC607 or placebo. Kidney recovery will be evaluated over the subsequent 30 days and death or the need for dialysis will be evaluated within 90 days of dosing. After 90 days (evaluation period), subjects will enter a 3-year extension phase of the study to monitor safety and long-term outcomes (follow-up period)."
      ],
      "BriefTitle": [
            "A Study to Evaluate the Safety and Efficacy of AC607 for the Treatment of Kidney Injury in Cardiac Surgery Subjects"
      ],
      "CentralContactEMail": [],
      "CentralContactName": [],
      "CentralContactPhone": [],
      "CentralContactPhoneExt": [],
      "CentralContactRole": [],
      "CollaboratorClass": [],
      "CollaboratorName": [],
      "CompletionDate": [
            "August 2014"
      ],
      "CompletionDateType": [
            "Actual"
      ],
      "Condition": [
            "Acute Kidney Injury"
      ],
      "ConditionAncestorId": [
            "D000051437",
            "D000007674",
            "D000014570"
      ],
      "ConditionAncestorTerm": [
            "Renal Insufficiency",
            "Kidney Diseases",
            "Urologic Diseases"
      ],
      "ConditionBrowseBranchAbbrev": [
            "BXS",
            "All",
            "BC26",
            "Rare"
      ],
      "ConditionBrowseBranchName": [
            "Urinary Tract, Sexual Organs, and Pregnancy Conditions",
            "All Conditions",
            "Wounds and Injuries",
            "Rare Diseases"
      ],
      "ConditionBrowseLeafAsFound": [
            "Acute Kidney Injury",
            "Injury"
      ],
      "ConditionBrowseLeafId": [
            "M28151",
            "M25871",
            "M16837",
            "M9850",
            "M16471",
            "T170"
      ],
      "ConditionBrowseLeafName": [
            "Acute Kidney Injury",
            "Renal Insufficiency",
            "Wounds and Injuries",
            "Kidney Diseases",
            "Urologic Diseases",
            "Acute Graft Versus Host Disease"
      ],
      "ConditionBrowseLeafRelevance": [
            "high",
            "low",
            "high",
            "low",
            "low",
            "low"
      ],
      "ConditionMeshId": [
            "D000058186",
            "D000014947"
      ],
      "ConditionMeshTerm": [
            "Acute Kidney Injury",
            "Wounds and Injuries"
      ],
      "DelayedPosting": [],
      "DesignAllocation": [
            "Randomized"
      ],
      "DesignInterventionModel": [
            "Parallel Assignment"
      ],
      "DesignInterventionModelDescription": [],
      "DesignMasking": [
            "Triple"
      ],
      "DesignMaskingDescription": [],
      "DesignObservationalModel": [],
      "DesignPrimaryPurpose": [
            "Treatment"
      ],
      "DesignTimePerspective": [],
      "DesignWhoMasked": [
            "Participant",
            "Care Provider",
            "Investigator"
      ],
      "DetailedDescription": [
            "The study will enroll post-cardiac surgery subjects (CABG and/or valve) with laboratory evidence of AKI within 48 hrs of removal from cardiopulmonary bypass. Subjects will be randomly assigned (1:1 ratio) to treatment with a single administration of AC607 or placebo (approximately 100 subjects per group).\n\nSafety and efficacy assessments will be performed daily during the post-operative hospital stay from the day randomized into the study until discharge, at 30 days, and at 90 days after study drug administration (evaluation phase). Safety and long-term clinical outcomes will be assessed at 6, 12, 24 and 36 months (long-term follow-up phase)."
      ],
      "DispFirstPostDate": [],
      "DispFirstPostDateType": [],
      "DispFirstSubmitDate": [],
      "DispFirstSubmitQCDate": [],
      "EligibilityCriteria": [
            "Inclusion Criteria:\n\nAge \u2265 21 years\nHad cardiovascular surgery utilizing cardiopulmonary bypass\nHave a pre-operative (baseline) serum creatinine value collected within 30 days of surgery (if multiple laboratory results are available within this time window, the most recent serum creatinine value prior to surgery will be used to establish the baseline)\nWilling and able to comply with visit schedule and study procedures including post-hospitalization discharge follow-up\nAbility to give informed consent or have a legally acceptable representative do so for them\nHave AKI defined as \u2265 0.5 mg/dL rise in serum creatinine from baseline within 48 hours of removal from cardiopulmonary bypass\n\nExclusion Criteria:\n\nActive cancer and/or receiving active treatment for cancer, with the exception of squamous cell or basal cell carcinoma of the skin\nHad surgery for thoraco-abdominal aortic aneurysm (TAAA)\nCurrently participating in another interventional drug or device clinical study\nPrisoner or other detainee\nHas a current medical condition that would preclude or compromise femoral artery catheter placement\nHas an intra-aortic balloon pump (IABP) in place within 2 hours of catheter placement\nHas a ventricular assist device (VAD) or extracorporeal membrane oxygenation (ECMO) in place at the time of the study catheter placement\nPrior history of solid organ or bone marrow transplant\nStage 5 CKD or currently on dialysis\nAre expected to receive dialysis within 24 hours of enrollment or dosing\nHad a complication during surgery or post-operatively that, in the opinion of the principal investigator (PI), significantly increases the risk of complications to the subject and therefore precludes dosing the subject\nAre pregnant or lactating. A woman with child-bearing potential may be tested for pregnancy at the discretion of the PI."
      ],
      "EnrollmentCount": [
            "156"
      ],
      "EnrollmentType": [
            "Actual"
      ],
      "EventGroupDeathsNumAffected": [],
      "EventGroupDeathsNumAtRisk": [],
      "EventGroupDescription": [],
      "EventGroupId": [],
      "EventGroupOtherNumAffected": [],
      "EventGroupOtherNumAtRisk": [],
      "EventGroupSeriousNumAffected": [],
      "EventGroupSeriousNumAtRisk": [],
      "EventGroupTitle": [],
      "EventsDescription": [],
      "EventsFrequencyThreshold": [],
      "EventsTimeFrame": [],
      "ExpAccTypeIndividual": [],
      "ExpAccTypeIntermediate": [],
      "ExpAccTypeTreatment": [],
      "ExpandedAccessNCTId": [],
      "ExpandedAccessStatusForNCTId": [],
      "FDAAA801Violation": [],
      "FlowAchievementComment": [],
      "FlowAchievementGroupId": [],
      "FlowAchievementNumSubjects": [],
      "FlowAchievementNumUnits": [],
      "FlowDropWithdrawComment": [],
      "FlowDropWithdrawType": [],
      "FlowGroupDescription": [],
      "FlowGroupId": [],
      "FlowGroupTitle": [],
      "FlowMilestoneComment": [],
      "FlowMilestoneType": [],
      "FlowPeriodTitle": [],
      "FlowPreAssignmentDetails": [],
      "FlowReasonComment": [],
      "FlowReasonGroupId": [],
      "FlowReasonNumSubjects": [],
      "FlowReasonNumUnits": [],
      "FlowRecruitmentDetails": [],
      "FlowTypeUnitsAnalyzed": [],
      "Gender": [
            "All"
      ],
      "GenderBased": [],
      "GenderDescription": [],
      "HasExpandedAccess": [
            "No"
      ],
      "HealthyVolunteers": [
            "No"
      ],
      "IPDSharing": [],
      "IPDSharingAccessCriteria": [],
      "IPDSharingDescription": [],
      "IPDSharingInfoType": [],
      "IPDSharingTimeFrame": [],
      "IPDSharingURL": [],
      "InterventionAncestorId": [],
      "InterventionAncestorTerm": [],
      "InterventionArmGroupLabel": [
            "AC607",
            "Placebo"
      ],
      "InterventionBrowseBranchAbbrev": [],
      "InterventionBrowseBranchName": [],
      "InterventionBrowseLeafAsFound": [],
      "InterventionBrowseLeafId": [],
      "InterventionBrowseLeafName": [],
      "InterventionBrowseLeafRelevance": [],
      "InterventionDescription": [
            "AC607 will be a single administration at a target dose of 2 x 10E6 hMSC/kg body weight",
            "The dose will be calculated and recorded in the same way as for AC607."
      ],
      "InterventionMeshId": [],
      "InterventionMeshTerm": [],
      "InterventionName": [
            "AC607",
            "Vehicle Only"
      ],
      "InterventionOtherName": [
            "allogeneic bone marrow-derived human mesenchymal",
            "stem cells"
      ],
      "InterventionType": [
            "Biological",
            "Biological"
      ],
      "IsFDARegulatedDevice": [],
      "IsFDARegulatedDrug": [],
      "IsPPSD": [],
      "IsUSExport": [],
      "IsUnapprovedDevice": [],
      "Keyword": [
            "Acute Kidney Injury",
            "Acute renal failure",
            "Human mesenchymal stem cells",
            "Allogeneic stem cells"
      ],
      "LargeDocDate": [],
      "LargeDocFilename": [],
      "LargeDocHasICF": [],
      "LargeDocHasProtocol": [],
      "LargeDocHasSAP": [],
      "LargeDocLabel": [],
      "LargeDocTypeAbbrev": [],
      "LargeDocUploadDate": [],
      "LastKnownStatus": [],
      "LastUpdatePostDate": [
            "August 6, 2014"
      ],
      "LastUpdatePostDateType": [
            "Estimate"
      ],
      "LastUpdateSubmitDate": [
            "August 5, 2014"
      ],
      "LeadSponsorClass": [
            "INDUSTRY"
      ],
      "LeadSponsorName": [
            "AlloCure Inc."
      ],
      "LimitationsAndCaveatsDescription": [],
      "LocationCity": [
            "Birmingham",
            "San Diego",
            "Stanford",
            "Washington",
            "Chicago",
            "Portland",
            "Baltimore",
            "Boston",
            "Boston",
            "Detroit",
            "Rochester",
            "New Brunswick",
            "New York",
            "Durham",
            "Columbus",
            "Wynnewood",
            "Houston",
            "Burlington",
            "Charlottesville",
            "Seattle",
            "Charleston",
            "Calgary",
            "Edmonton",
            "Winnipeg",
            "Halifax",
            "Hamilton",
            "London",
            "Toronto",
            "Toronto",
            "Montreal",
            "Quebec"
      ],
      "LocationContactEMail": [],
      "LocationContactName": [],
      "LocationContactPhone": [],
      "LocationContactPhoneExt": [],
      "LocationContactRole": [],
      "LocationCountry": [
            "United States",
            "United States",
            "United States",
            "United States",
            "United States",
            "United States",
            "United States",
            "United States",
            "United States",
            "United States",
            "United States",
            "United States",
            "United States",
            "United States",
            "United States",
            "United States",
            "United States",
            "United States",
            "United States",
            "United States",
            "United States",
            "Canada",
            "Canada",
            "Canada",
            "Canada",
            "Canada",
            "Canada",
            "Canada",
            "Canada",
            "Canada",
            "Canada"
      ],
      "LocationFacility": [
            "University of Alabama at Birmingham",
            "University of California, San Diego",
            "Stanford Hospital and Clinics",
            "MedStar Washington Hospital Center",
            "Northwestern University",
            "Maine Medical Center",
            "Johns Hopkins University",
            "Brigham and Women's Hospital",
            "Beth Israel Deaconess Medical Center",
            "Henry Ford Hospital",
            "Mayo Clinic",
            "Rutgers Robert Wood Johnson Medical School",
            "Columbia University Medical Center",
            "Duke University Medical Center",
            "Ohio State University",
            "Lankenau Medical Center",
            "UTHealth, The University of Texas Health Science Center at Houston",
            "Fletcher Allen Health Care - Renal Services",
            "University of Virginia Health System",
            "University of Washington Medical Center",
            "CAMC Clinical Trials Center",
            "Foothills Medical Centre",
            "University of Alberta Hospital",
            "University of Manitoba - St. Boniface Hospital",
            "CDHA Queen Elizabeth II Health Sciences Centre",
            "McMaster - Hamilton General Hospital / TAARI",
            "London Health Sciences Centre, University Hospital",
            "St. Michael's Hospital",
            "Toronto General Hospital",
            "Montreal Heart Institute",
            "Institut Universitaire de Cardiologie et de Pneumologie de Quebec"
      ],
      "LocationState": [
            "Alabama",
            "California",
            "California",
            "District of Columbia",
            "Illinois",
            "Maine",
            "Maryland",
            "Massachusetts",
            "Massachusetts",
            "Michigan",
            "Minnesota",
            "New Jersey",
            "New York",
            "North Carolina",
            "Ohio",
            "Pennsylvania",
            "Texas",
            "Vermont",
            "Virginia",
            "Washington",
            "West Virginia",
            "Alberta",
            "Alberta",
            "Manitoba",
            "Nova Scotia",
            "Ontario",
            "Ontario",
            "Ontario",
            "Ontario",
            "Quebec"
      ],
      "LocationStatus": [],
      "LocationZip": [
            "35294",
            "92103",
            "94305-2299",
            "20010",
            "60611",
            "04102",
            "21287",
            "02115",
            "02215",
            "48202",
            "55905",
            "08903",
            "10032",
            "27710",
            "43210",
            "19096",
            "77030",
            "05401",
            "22908",
            "98195",
            "25304",
            "T2N 2T9",
            "T6G 2B7",
            "R2H 2A6",
            "B3H 3A7",
            "L8L 2X2",
            "N6J 1S1",
            "M5B 1W8",
            "M5G 2C4",
            "H1T 1C8",
            "G1V 4G5"
      ],
      "MaximumAge": [],
      "MinimumAge": [
            "21 Years"
      ],
      "NCTIdAlias": [],
      "OfficialTitle": [
            "A Randomized, Multicenter, Double-Blind, Placebo-Controlled Study of AC607 for the Treatment of Acute Kidney Injury in Cardiac Surgery Subjects"
      ],
      "OrgClass": [
            "INDUSTRY"
      ],
      "OrgFullName": [
            "AlloCure Inc."
      ],
      "OrgStudyId": [
            "AC 6071103"
      ],
      "OrgStudyIdDomain": [],
      "OrgStudyIdLink": [],
      "OrgStudyIdType": [],
      "OtherEventAssessmentType": [],
      "OtherEventNotes": [],
      "OtherEventOrganSystem": [],
      "OtherEventSourceVocabulary": [],
      "OtherEventStatsGroupId": [],
      "OtherEventStatsNumAffected": [],
      "OtherEventStatsNumAtRisk": [],
      "OtherEventStatsNumEvents": [],
      "OtherEventTerm": [],
      "OtherOutcomeDescription": [],
      "OtherOutcomeMeasure": [],
      "OtherOutcomeTimeFrame": [],
      "OutcomeAnalysisCILowerLimit": [],
      "OutcomeAnalysisCILowerLimitComment": [],
      "OutcomeAnalysisCINumSides": [],
      "OutcomeAnalysisCIPctValue": [],
      "OutcomeAnalysisCIUpperLimit": [],
      "OutcomeAnalysisCIUpperLimitComment": [],
      "OutcomeAnalysisDispersionType": [],
      "OutcomeAnalysisDispersionValue": [],
      "OutcomeAnalysisEstimateComment": [],
      "OutcomeAnalysisGroupDescription": [],
      "OutcomeAnalysisGroupId": [],
      "OutcomeAnalysisNonInferiorityComment": [],
      "OutcomeAnalysisNonInferiorityType": [],
      "OutcomeAnalysisOtherAnalysisDescription": [],
      "OutcomeAnalysisPValue": [],
      "OutcomeAnalysisPValueComment": [],
      "OutcomeAnalysisParamType": [],
      "OutcomeAnalysisParamValue": [],
      "OutcomeAnalysisStatisticalComment": [],
      "OutcomeAnalysisStatisticalMethod": [],
      "OutcomeAnalysisTestedNonInferiority": [],
      "OutcomeCategoryTitle": [],
      "OutcomeClassDenomCountGroupId": [],
      "OutcomeClassDenomCountValue": [],
      "OutcomeClassDenomUnits": [],
      "OutcomeClassTitle": [],
      "OutcomeDenomCountGroupId": [],
      "OutcomeDenomCountValue": [],
      "OutcomeDenomUnits": [],
      "OutcomeGroupDescription": [],
      "OutcomeGroupId": [],
      "OutcomeGroupTitle": [],
      "OutcomeMeasureAnticipatedPostingDate": [],
      "OutcomeMeasureCalculatePct": [],
      "OutcomeMeasureDenomUnitsSelected": [],
      "OutcomeMeasureDescription": [],
      "OutcomeMeasureDispersionType": [],
      "OutcomeMeasureParamType": [],
      "OutcomeMeasurePopulationDescription": [],
      "OutcomeMeasureReportingStatus": [],
      "OutcomeMeasureTimeFrame": [],
      "OutcomeMeasureTitle": [],
      "OutcomeMeasureType": [],
      "OutcomeMeasureTypeUnitsAnalyzed": [],
      "OutcomeMeasureUnitOfMeasure": [],
      "OutcomeMeasurementComment": [],
      "OutcomeMeasurementGroupId": [],
      "OutcomeMeasurementLowerLimit": [],
      "OutcomeMeasurementSpread": [],
      "OutcomeMeasurementUpperLimit": [],
      "OutcomeMeasurementValue": [],
      "OverallOfficialAffiliation": [],
      "OverallOfficialName": [
            "Viken Paragamian"
      ],
      "OverallOfficialRole": [
            "Study Director"
      ],
      "OverallStatus": [
            "Terminated"
      ],
      "OversightHasDMC": [
            "Yes"
      ],
      "PatientRegistry": [],
      "Phase": [
            "Phase 2"
      ],
      "PointOfContactEMail": [],
      "PointOfContactOrganization": [],
      "PointOfContactPhone": [],
      "PointOfContactPhoneExt": [],
      "PointOfContactTitle": [],
      "PrimaryCompletionDate": [
            "June 2014"
      ],
      "PrimaryCompletionDateType": [
            "Actual"
      ],
      "PrimaryOutcomeDescription": [
            "The first occurrence of a post-dosing serum creatinine level that is equal to or less than the subject's pre-operative baseline level."
      ],
      "PrimaryOutcomeMeasure": [
            "Time to Kidney Recovery defined as a post-operative serum creatinine return to pre-operative baseline values."
      ],
      "PrimaryOutcomeTimeFrame": [
            "Within 30 days of dosing."
      ],
      "ReferenceCitation": [
            "Zhao L, Hu C, Zhang P, Jiang H, Chen J. Preconditioning strategies for improving the survival rate and paracrine ability of mesenchymal stem cells in acute kidney injury. J Cell Mol Med. 2019 Feb;23(2):720-730. doi: 10.1111/jcmm.14035. Epub 2018 Nov 28. Review."
      ],
      "ReferencePMID": [
            "30484934"
      ],
      "ReferenceType": [
            "derived"
      ],
      "RemovedCountry": [],
      "ResponsiblePartyInvestigatorAffiliation": [],
      "ResponsiblePartyInvestigatorFullName": [],
      "ResponsiblePartyInvestigatorTitle": [],
      "ResponsiblePartyOldNameTitle": [],
      "ResponsiblePartyOldOrganization": [],
      "ResponsiblePartyType": [
            "Sponsor"
      ],
      "ResultsFirstPostDate": [],
      "ResultsFirstPostDateType": [],
      "ResultsFirstPostedQCCommentsDate": [],
      "ResultsFirstPostedQCCommentsDateType": [],
      "ResultsFirstSubmitDate": [],
      "ResultsFirstSubmitQCDate": [],
      "RetractionPMID": [],
      "RetractionSource": [],
      "SamplingMethod": [],
      "SecondaryId": [],
      "SecondaryIdDomain": [],
      "SecondaryIdLink": [],
      "SecondaryIdType": [],
      "SecondaryOutcomeDescription": [],
      "SecondaryOutcomeMeasure": [
            "All-Cause Mortality or Dialysis (composite endpoint)."
      ],
      "SecondaryOutcomeTimeFrame": [
            "Subjects who died or received dialysis within 30 and 90 days after dosing."
      ],
      "SeeAlsoLinkLabel": [],
      "SeeAlsoLinkURL": [],
      "SeriousEventAssessmentType": [],
      "SeriousEventNotes": [],
      "SeriousEventOrganSystem": [],
      "SeriousEventSourceVocabulary": [],
      "SeriousEventStatsGroupId": [],
      "SeriousEventStatsNumAffected": [],
      "SeriousEventStatsNumAtRisk": [],
      "SeriousEventStatsNumEvents": [],
      "SeriousEventTerm": [],
      "StartDate": [
            "June 2012"
      ],
      "StartDateType": [],
      "StatusVerifiedDate": [
            "August 2014"
      ],
      "StdAge": [
            "Adult",
            "Older Adult"
      ],
      "StudyFirstPostDate": [
            "May 21, 2012"
      ],
      "StudyFirstPostDateType": [
            "Estimate"
      ],
      "StudyFirstSubmitDate": [
            "May 17, 2012"
      ],
      "StudyFirstSubmitQCDate": [
            "May 17, 2012"
      ],
      "StudyPopulation": [],
      "StudyType": [
            "Interventional"
      ],
      "SubmissionMCPReleaseN": [],
      "SubmissionReleaseDate": [],
      "SubmissionResetDate": [],
      "SubmissionUnreleaseDate": [],
      "TargetDuration": [],
      "UnpostedEventDate": [],
      "UnpostedEventType": [],
      "UnpostedResponsibleParty": [],
      "VersionHolder": [
            "October 10, 2022"
      ],
      "WhyStopped": []
}